Session 1296: Novel Therapies, Part 2
Cochair(s): WT Beck, H de The
Date: Tue 12 February 2002,
Time: 14:00 - 16:00
Location: Amphithéâtre Monod
Oral Presentations
| Time |
Number |
Title / Authors / Affiliations |
| 14:00 |
494 |
Tumor treatment
by a new system for focalized therapy assessed on an
animal model
EMH Hiltbrand, G Quash, H Fessi, F Buchegger, T Binzoni,
J Belenger, M Costa, J Foray, H Mehier
1Univ.
hospital Geneva, Geneva, Geneva Switzerland,
2University Hospital, Lyon-Sud, France,
3LAGEP Lyon-1, France, , 4CERMA
Archamps, France |
| 14:15 |
495 |
Detection of
therapeutical effects by anti-EGFR therapy alone and in
combination with chemotherapeutics against human squamous
cell carcinomas of the head and neck using microarray
techniques
MH Hambek
University of Frankfurt
Medical School, Frankfurt / Main, Hessen
Germany |
| 14:30 |
496 |
Potential role of
extracorporeal photochemotherapy in antineoplastic
treatment
U Prati, C Perotti, L Roveda, F Trotta, P Valsecchi, D
Roberto, C Rossella, C Zonta, A Clerici, C Ferrari, GL
Viarengo, S Bernuzzi, D Fante, L Salvaneschi
1Chirurgia
Sperimentale e Tecnologie Chirurgiche Innovative,
Policlinico San Matteo, Pavia, PV Italy,
2Chirurgia Epatopancreatica, Policlinico San
Matteo, Pavia, PV Italy, 3Dipartimento di
Chirurgia, Universita' degli Studi di Pavia, Italy,
Pavia, 4Servizio di Immunoematologia e
Trasfusione, Policlinico San Matteo, Pavia, PV
Italy |
| 14:45 |
497 |
Expression of EAG
potasssium channels in tumor tissue
MD LA Pardo, B Hemmerlein, A Sánchez, HJ Radzun, W
Stühmer
1iOnGen AG,
Goettingen, Germany, 2Max-Planck-Insitute for
Experimental Medicine, Göttingen, Germany,
3Department of Pathology, University Hospital
Göttingen, Germany |
| 15:00 |
498 |
Expression and
regulation of the Coxsackie- and Adenovirus Receptor
(CAR) in premalignant lesions and advanced
neoplasms.
M Anders, C Christian, RS Warren, A Balmain, MJ Bissell,
WM Korn
1Comprehensive
Cancer Center, San Francisco, CA and,
2Department of Surgery, 3Division
of Gastroenterology; University of California San
Francisco, San Francisco, CA and, 4Lawrence
Berkeley National Laboratory, Berkeley, United
States |
| 15:15 |
499 |
*Survival of
colorectal cancer patients with high levels of sialyl
lewis-x and sialyl lewis-a epitope expression on tumor
cells was improved by cimetidine
SM Matsumoto
Fujita Health
University, Second Teaching Hospital, Nagoya, Aichi
Japan |
| 15:30 |
500 |
Conditional
mutation of the ErbB2 (HER2) receptor in cardiomyocytes
leads to dilated cardiomyopathy
AN Garratt, B Erdmann, B Pilz, N Wettschureck, S Britsch,
N Huebner, KR Chien, C Birchmeier
1Max-Delbrueck-Center
for Molecular Medicine, Germany, CA,
2Franz-Volhard-Klinik, Germany, CA,
3University of Heidelberg, Germany, CA,
4University of California San Diego, Medical
School, La Jolla, USA |
| 15:45 |
501 |
Recombinant
adenovirus AdTIMP-2 inhibits tumor growth, angiogenesis
and metastasis, and prolongs survival in
mice
H Li, F Lidenmeyer, C Grenet, P Opolon, S Menashi, C
Soria, P Yeh, M Perricaudet, H Lu
CNRS UMR 1582, Institut
Gustave Roussy, Rue C. Desmoulins Villejuif,
France |
|
Site Contents
- The Journal
- CDP, a peer-refereed
bi-monthly on predictive and preventive oncology
- The Society
- The International Society for Preventive
Oncology
- Meetings
- Network and earn CME credits at our
international symposia.
|
